LDN Social Media
Get connected with us on social networks
Dr Derek Enlander Talks about Low Dose Naltrexone LDN, CFS/ME 2021 (LDN) from LDN Research Trust on Vimeo.
Dr. Derek Enlander shares his knowledge about myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) which is a disabling and complex illness. People with ME/CFS are often not able to do their usual activities due to extreme fatigue. At times, ME/CFS may confine them to bed. Low Dose Naltrexone (LDN) is very effective in improving the immune system and reducing or removing the symptoms.
Review by Ken Bruce
Derek Enlander, MD, is an Internist specializing in ME/CFS, fibromyalgia, and Lyme disease. Though originally from Belfast in Northern Ireland (UK), he now works in New York City, New York, United States. He is a clinical instructor at The Icahn School of Medicine at Mount Sinai and leads the CFS Center at Mount Sinai Hospital in New York City. Committed to introducing the next generation of doctors to the best training in ME/CFS, he frequently has medical students and interns shadow him in his office.